METHOD FOR IDENTIFYING HARD-TO-TREAT OSTEOSARCOMA PATIENTS AT DIAGNOSIS AND IMPROVING… Application WO-2022157341-A1 World Intellectual Property Organisation (WIPO) 28 Jul 2022
METHOD FOR IDENTIFYING HARD-TO-TREAT OSTEOSARCOMA PATIENTS AT DIAGNOSIS AND IMPROVING… Application EP-4032988-A1 European Patent Office 27 Jul 2022
LENVATINIB IN COMBINATION WITH ETOPOSIDE AND IFOSFAMIDE FOR USE IN TREATING A TUMOR Grant EP-3338779-B1 European Patent Office 30 Jun 2021
MELFLUFEN FORMULATIONS AND THEIR USE IN THE TREATMENT OR PROPHYLAXIS OF OSTEOSARCOMA Application WO-2021053185-A1 World Intellectual Property Organisation (WIPO) 25 Mar 2021